{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:00:16Z","timestamp":1790100016618,"version":"4.0.1"},"reference-count":160,"publisher":"Elsevier","isbn-type":[{"value":"9780443184321","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.ircmb.2023.03.005","type":"book-chapter","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:56:52Z","timestamp":1682103412000},"page":"157-200","source":"Crossref","is-referenced-by-count":8,"title":["Radiation therapy-activated nanoparticle and immunotherapy: The next milestone in oncology?"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.ircmb.2023.03.005_bb0010","doi-asserted-by":"crossref","first-page":"1900411","DOI":"10.1002\/ppsc.201900411","article-title":"Radiobiological implications of nanoparticles following radiation treatment","volume":"37","author":"Ahmad","year":"2020","journal-title":"Part Part Syst. Charact."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/mp.14697","article-title":"Bismuth oxide nanoparticles as agents of radiation dose enhancement in intraoperative radiotherapy","volume":"48","author":"Alyani Nezhad","year":"2021","journal-title":"Med. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of Cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol. Annu. Rev. Pathol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2021.109432","article-title":"Efficacy of various nanoparticle types in dose enhancement during low energy X-ray IORT: a Monte Carlo simulation study","volume":"183","author":"Baghani","year":"2021","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrclinonc.2016.30","article-title":"Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?","volume":"13","author":"Bernstein","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0035","article-title":"Radiation-induced immune response in novel radiotherapy approaches FLASH and spatially fractionated radiotherapies","author":"Bertho","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10256","article-title":"Radiation nanosensitizers in cancer therapy-from preclinical discoveries to the outcomes of early clinical trials","volume":"7","author":"Bilynsky","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2022.07.001","article-title":"Final safety and health-related quality of LIfe results of the phase 2\/3 act.In.Sarc study with preoperative NBTXR3 plus radiation therapy versus radiation therapy in locally advanced soft-tissue sarcoma","volume":"114","author":"Bonvalot","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194893","article-title":"Anti-PD-1\/anti-PD-L1 drugs and radiation therapy: combinations and optimization strategies","volume":"13","author":"Boustani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0055","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0060","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1021\/acs.iecr.8b02526","article-title":"Facile one-pot synthesis of intrinsically radiolabeled and cyclic RGD conjugated 199Au nanoparticles for potential use in nanoscale brachytherapy","volume":"57","author":"Chakravarty","year":"2018","journal-title":"Industrial & Engineering Chemistry Research"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.semcancer.2022.04.003","article-title":"Radiation therapy-induced remodeling of the tumor immune microenvironment","volume":"86","author":"Charpentier","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0070","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/ja210239k","article-title":"Chemical enhancement by nanomaterials under X-ray irradiation","volume":"134","author":"Cheng","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102835","article-title":"Understanding the effects of radiotherapy on the tumour immune microenvironment to identify potential prognostic and predictive biomarkers of radiotherapy response","volume":"12","author":"Cheng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0080","article-title":"Targeting STING to promote antitumor immunity","author":"Chin","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1667\/RR1984.1","article-title":"Gold nanoparticles as radiation sensitizers in cancer therapy","volume":"173","author":"Chithrani","year":"2010","journal-title":"Radiat. Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0090","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/smll.201000463","article-title":"The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles","volume":"6","author":"Chompoosor","year":"2010","journal-title":"Small"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010121","article-title":"Influence of radiotherapy fractionation schedule on the tumor vascular microenvironment in prostate and lung Cancer models","volume":"12","author":"Clement-Colmou","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.699822","article-title":"Radiosensitization effect of gold nanoparticles in proton therapy","volume":"9","author":"Cunningham","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0105","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.2147\/IJN.S203546","article-title":"Gold nanoparticles affect the antioxidant status in selected normal human cells","volume":"14","author":"Daems","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12935-022-02615-w","article-title":"Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire","volume":"22","author":"Darmon","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/2326-6066.CIR-19-0305","article-title":"Activin a promotes regulatory T-cell-mediated immunosuppression in irradiated breast Cancer","volume":"9","author":"De Martino","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0125","doi-asserted-by":"crossref","first-page":"20200042","DOI":"10.1259\/bjr.20200042","article-title":"The abscopal effect 67 years later: from a side story to center stage","volume":"93","author":"Demaria","year":"2020","journal-title":"Br. J. Radiol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002038","article-title":"Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?","volume":"9","author":"Demaria","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2016.07.021","article-title":"Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy","volume":"238","author":"Detappe","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0150","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100970","article-title":"Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy","volume":"35","author":"Ding","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0160","series-title":"Normal Tissue Radiobiology","author":"D\u00f6rr","year":"2014"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0165","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/smll.201401284","article-title":"Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization","volume":"11","author":"Dufort","year":"2015","journal-title":"Small"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrclinonc.2009.183","article-title":"Charged particles in radiation oncology","volume":"7","author":"Durante","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1535-7163.MCT-21-0358","article-title":"Abdominopelvic FLASH irradiation improves PD-1 immune checkpoint inhibition in preclinical models of ovarian Cancer","volume":"21","author":"Eggold","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/09553002.2018.1407462","article-title":"Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons","volume":"94","author":"Enferadi","year":"2018","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0190","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lungcan.2020.11.024","article-title":"Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable stage III NSCLC (PACIFIC)","volume":"151","author":"Faivre-Finn","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0200","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.7150\/thno.42471","article-title":"Ultrasmall gold nanoparticles in cancer diagnosis and therapy","volume":"10","author":"Fan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0205","first-page":"621","article-title":"Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. International journal of radiation oncology* biology*","volume":"7","author":"Fertil","year":"1981","journal-title":"Phys. Ther."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijrobp.2010.06.056","article-title":"Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks","volume":"78","author":"Ganem","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0215","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1158\/0008-5472.CAN-04-1525","article-title":"Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes","volume":"64","author":"Garnett","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0220","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-018-0757-9","article-title":"Proton irradiation orchestrates macrophage reprogramming through NFkappaB signaling","volume":"9","author":"Genard","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0225","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.colsurfb.2014.10.028","article-title":"Gold nanoparticles functionalization notably decreases radiosensitization through hydroxyl radical production under ionizing radiation","volume":"123","author":"Gilles","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40425-019-0634-9","article-title":"Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination","volume":"7","author":"Grapin","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109225","article-title":"Synergistic combination therapy of lung cancer: cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0240","article-title":"RGD-functionalized magnetosomes are efficient tumor radioenhancers for X-rays and protons","volume":"23","author":"Hafsi","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0245","doi-asserted-by":"crossref","first-page":"N309","DOI":"10.1088\/0031-9155\/49\/18\/N03","article-title":"The use of gold nanoparticles to enhance radiotherapy in mice","volume":"49","author":"Hainfeld","year":"2004","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0250","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1021\/acsnano.5b01324","article-title":"Positron emission tomography based elucidation of the enhanced permeability and retention effect in dogs with Cancer using Copper-64 liposomes","volume":"9","author":"Hansen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0255","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","author":"Harrington","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0260","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2020.09.041","article-title":"Reduction of lung metastases in a mouse osteosarcoma model treated with carbon ions and immune checkpoint inhibitors","volume":"109","author":"Helm","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0265","article-title":"Are charged particles a good match for combination with immunotherapy? Current knowledge and perspectives","author":"Helm","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12951-021-01163-1","article-title":"A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model","volume":"19","author":"Hu","year":"2021","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0275","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijrobp.2021.06.041","article-title":"Radiation therapy enhanced by NBTXR3 nanoparticles overcomes anti-PD1 resistance and evokes abscopal effects","volume":"111","author":"Hu","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0280","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41578-021-00385-x","article-title":"Clinical translation of silica nanoparticles","volume":"6","author":"Janjua","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0285","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1088\/0031-9155\/59\/21\/6431","article-title":"Investigation of gold nanoparticle radiosensitization mechanisms using a free radical scavenger and protons of different energies","volume":"59","author":"Jeynes","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0290","first-page":"14","article-title":"A 'Hybrid' radiotherapy regimen designed for immunomodulation: combining high-dose radiotherapy with low-dose radiotherapy","author":"Ji","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0295","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246193","article-title":"Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of Rtog0617","volume":"13","author":"Jin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010563","article-title":"Investigation of the antibacterial properties of silver-doped amorphous carbon coatings produced by low pressure magnetron assisted acetylene discharges","volume":"23","author":"Job","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0310","series-title":"Basic clinical radiobiology","author":"Joiner","year":"2018"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","article-title":"Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma","volume":"23","author":"Kalbasi","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0320","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction Cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0325","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0330","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2020.11.012","article-title":"Effects of ultra-high doserate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain","volume":"109","author":"Kim","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0335","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS(+)\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31083\/j.fbs1401002","article-title":"Influence of photon, proton and carbon ion irradiation on differentiation, maturation and functionality of dendritic cells","volume":"14","author":"Konig","year":"2022","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0345","doi-asserted-by":"crossref","first-page":"35053","DOI":"10.1038\/srep35053","article-title":"Safety evaluation and imaging properties of gadolinium-based nanoparticles in nonhuman primates","volume":"6","author":"Kotb","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0355","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-Small cell lung Cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2018.01.071","article-title":"Targeting myeloid-derived suppressor cells and programmed death ligand 1 confers therapeutic advantage of ablative Hypofractionated radiation therapy compared with conventional fractionated radiation therapy","volume":"101","author":"Lan","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0370","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2013.10.115","article-title":"SPION primes THP1 derived M2 macrophages towards M1-like macrophages","volume":"441","author":"Laskar","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0375","first-page":"116","article-title":"In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response","volume":"24","author":"Laurent","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0380","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12645-014-0004-8","article-title":"Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment","volume":"5","author":"Le Duc","year":"2014","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0385","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038391","article-title":"Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol","volume":"10","author":"Le Guevelou","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0390","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0395","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2217\/nnm-2018-0161","article-title":"Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy","volume":"14","author":"Li","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0400","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/45\/455101","article-title":"LET-dependent radiosensitization effects of gold nanoparticles for proton irradiation","volume":"27","author":"Li","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0405","article-title":"Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma","volume":"5","author":"Liniker","year":"2016","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0410","first-page":"11","article-title":"Titanate nanotubes engineered with gold nanoparticles and docetaxel to enhance radiotherapy on xenografted prostate tumors","author":"Loiseau","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0415","article-title":"Narrative review of Synergistics effects of combining immunotherapy and stereotactic radiation therapy","volume":"10","author":"Lucia","year":"2022","journal-title":"Biomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081825","article-title":"Recent development of gold nanoparticles as contrast agents for Cancer diagnosis","volume":"13","author":"Luo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0425","first-page":"20180365","article-title":"AGuIX((R)) from bench to bedside-transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine","volume":"92","author":"Lux","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0430","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0435","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2217\/fon.12.96","article-title":"Nanoscale radiotherapy with hafnium oxide nanoparticles","volume":"8","author":"Maggiorella","year":"2012","journal-title":"Future Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0440","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","article-title":"Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy","volume":"24","author":"Marciscano","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0445","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.radonc.2019.07.029","article-title":"DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells","volume":"141","author":"Marill","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.107905","article-title":"Antimicrobial properties and applications of metal nanoparticles biosynthesized by green methods","volume":"58","author":"Matatkova","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0455","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0460","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1002\/cncr.25134","article-title":"Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma","volume":"116","author":"Matsunaga","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/srep00018","article-title":"Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles","volume":"1","author":"McMahon","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020336","article-title":"The current state of nanoparticle-induced macrophage polarization and reprogramming research","volume":"18","author":"Miao","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0475","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.2147\/IJN.S139167","article-title":"Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model","volume":"12","author":"Mirjolet","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0480","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1038\/s41598-021-92942-1","article-title":"Impact of proton therapy on antitumor immune response","volume":"11","author":"Mirjolet","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0485","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized Ultrafractionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade","volume":"110","author":"Moore","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0490","article-title":"PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation","volume":"7","author":"Morisada","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/nano10050952","article-title":"Radiosensitization by gold nanoparticles: impact of the size, dose rate, and photon energy","volume":"10","author":"Morozov","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0500","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/2277-9175.153893","article-title":"The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition","volume":"4","author":"Negahdary","year":"2015","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0505","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0510","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-018-04703-w","article-title":"Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0515","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0520","doi-asserted-by":"crossref","first-page":"18483","DOI":"10.1039\/D1NR03201A","article-title":"Two step promotion of a hot tumor immune environment by gold decorated iron oxide nanoflowers and light-triggered mild hyperthermia","volume":"13","author":"Nicolas-Boluda","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0525","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1080\/09553002.2020.1807644","article-title":"Proton scanning and X-ray beam irradiation induce distinct regulation of inflammatory cytokines in a preclinical mouse model","volume":"96","author":"Nielsen","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0530","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","article-title":"Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect","volume":"3","author":"Nishiga","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0535","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ijrobp.2010.06.048","article-title":"Combining carbon ion radiotherapy and local injection of alpha-galactosylceramide-pulsed dendritic cells inhibits lung metastases in an in vivo murine model","volume":"78","author":"Ohkubo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0540","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2021.08.015","article-title":"Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy","volume":"112","author":"Paganetti","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0545","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/ed045p581","article-title":"Hard and soft acids and bases. 1. Fundamental Principles","volume":"45","author":"Pearson","year":"1968","journal-title":"J. Chem. Ed."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0550","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/radiation1040025","article-title":"Metallic nanoparticles: a useful prompt gamma emitter for range monitoring in proton therapy?","volume":"1","author":"Penninckx","year":"2021","journal-title":"Radiation"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0555","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.2217\/nnm-2018-0171","article-title":"The role of thioredoxin reductase in gold nanoparticle radiosensitization effects","volume":"13","author":"Penninckx","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/nano9020295","article-title":"Thioredoxin reductase activity predicts gold nanoparticle Radiosensitization effect","volume":"9","author":"Penninckx","year":"2019","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082021","article-title":"Gold nanoparticles as a potent radiosensitizer: a transdisciplinary approach from physics to patient","volume":"12","author":"Penninckx","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0570","first-page":"zcab046","article-title":"Quantification of radiation-induced DNA double strand break repair foci to evaluate and predict biological responses to ionizing radiation. NAR","volume":"3","author":"Penninckx","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0575","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmp.2018.03.004","article-title":"Metallic nanoparticle radiosensitisation of ion radiotherapy: a review","volume":"47","author":"Peukert","year":"2018","journal-title":"Phys. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0580","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3857\/roj.2021.00115","article-title":"Abscopal effect in the radio and immunotherapy","volume":"39","author":"Pevzner","year":"2021","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0585","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.nano.2014.05.005","article-title":"Gadolinium-based nanoparticles to improve the hadrontherapy performances","volume":"10","author":"Porcel","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0590","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0595","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0600","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1535-7163.MCT-18-0986","article-title":"PD-1\/PD-L1 immune checkpoint inhibition with radiation in bladder Cancer: in situ and abscopal effects","volume":"19","author":"Rompre-Brodeur","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/bs.ircmb.2023.03.005_bb0605","first-page":"1016","article-title":"Effect of radiation dose fractionation and radiation energy on gold nanoparticle enhancement of radiation therapy","volume":"3","author":"Sah","year":"2020","journal-title":"J. Nanomed."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020188","article-title":"A proof-of-concept study on the therapeutic potential of au nanoparticles radiolabeled with the alpha-emitter Actinium-225","volume":"12","author":"Salvanou","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0615","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-017-01883-9","article-title":"DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells","volume":"8","author":"Sato","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0620","doi-asserted-by":"crossref","first-page":"21RM02","DOI":"10.1088\/1361-6560\/ab9159","article-title":"Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions","volume":"65","author":"Schuemann","year":"2020","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.766407","article-title":"Recent advances in brachytherapy using radioactive nanoparticles: An alternative to seed-based brachytherapy","volume":"11","author":"Seniwal","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0630","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/smll.201400110","article-title":"A new mechanism for hydroxyl radical production in irradiated nanoparticle solutions","volume":"10","author":"Sicard-Roselli","year":"2014","journal-title":"Small"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0635","first-page":"1","article-title":"Nanoparticles for MRI-guided radiation therapy: a review","volume":"13","author":"Smith","year":"2022","journal-title":"Cancer Nanotechnol."},{"issue":"31","key":"10.1016\/bs.ircmb.2023.03.005_bb806","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1039\/D2NR02620A","article-title":"Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy","volume":"14","author":"Song","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0645","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-Small-cell lung Cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0650","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s43018-022-00467-x","article-title":"Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade","volume":"3","author":"Spurr","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0655","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000667","article-title":"Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer","volume":"8","author":"Stary","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0660","first-page":"1229","article-title":"Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma","volume":"63","author":"Stone","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0665","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12951-022-01654-9","article-title":"AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway","volume":"20","author":"Sun","year":"2022","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0670","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12645-014-0005-7","article-title":"The role of mitochondrial function in gold nanoparticle mediated radiosensitisation","volume":"5","author":"Taggart","year":"2014","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0675","doi-asserted-by":"crossref","first-page":"633","DOI":"10.18632\/oncotarget.26551","article-title":"Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma","volume":"10","author":"Takahashi","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0680","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4143\/crt.2022.1460","article-title":"Top ten lessons learned from trials in oligometastatic cancers","volume":"55","author":"Tan","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0685","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annonc.2022.10.006","article-title":"Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial","volume":"34","author":"Tao","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0690","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/nano13010201","article-title":"Advances in the mechanistic understanding of Iron oxide Nanoparticles' radiosensitizing properties","volume":"13","author":"Ternad","year":"2023","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133185","article-title":"Requirements for designing an effective metallic nanoparticle (NP)-boosted radiation therapy (RT)","volume":"13","author":"Tremi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0705","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/path.1700640403","article-title":"The sensitivity of lymphocytes to ionising radiation","volume":"64","author":"Trowell","year":"1952","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0710","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17425247.2019.1554647","article-title":"Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics","volume":"16","author":"Vangijzegem","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0715","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0720","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): a systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0730","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.04.021","article-title":"Theranostic AGuIX nanoparticles as radiosensitizer: a phase I, dose-escalation study in patients with multiple brain metastases (Nano-RAD trial)","volume":"160","author":"Verry","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0735","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0740","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1088\/0031-9155\/59\/6\/1441","article-title":"Simulations of dose enhancement for heavy atom nanoparticles irradiated by protons","volume":"59","author":"Walzlein","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0745","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg0117","article-title":"Sequence of alphaPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses","volume":"6","author":"Wei","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0750","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0755","first-page":"8","article-title":"Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I\/II trial","author":"Welsh","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0760","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2017.00229","article-title":"Barriers to radiation-induced in situ tumor vaccination","volume":"8","author":"Wennerberg","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0765","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/2326-6066.CIR-19-0449","article-title":"CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection","volume":"8","author":"Wennerberg","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0770","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3389\/fonc.2019.01563","article-title":"Ultra-high dose rate (FLASH) radiotherapy: silver bullet or Fool's gold?","volume":"9","author":"Wilson","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0780","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/smll.200900126","article-title":"Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes","volume":"5","author":"Yen","year":"2009","journal-title":"Small"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0785","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.2147\/IJN.S250490","article-title":"Radiotherapy-activated hafnium oxide nanoparticles produce abscopal effect in a mouse colorectal Cancer model","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091768","article-title":"Immune modulatory effects of molecularly targeted therapy and its repurposed usage in Cancer immunotherapy","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0795","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fbioe.2020.00537","article-title":"Differently charged super-paramagnetic Iron oxide nanoparticles preferentially induced M1-like phenotype of macrophages","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0800","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clon.2021.09.003","article-title":"Can rational combination of ultra-high dose rate FLASH radiotherapy with immunotherapy provide a novel approach to Cancer treatment?","volume":"33","author":"Zhang","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/bs.ircmb.2023.03.005_bb0805","first-page":"2057892","article-title":"Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice","volume":"11","author":"Zhou","year":"2022","journal-title":"Onco. Targets. Ther."}],"container-title":["International Review of Cell and Molecular Biology","Ionizing Radiation and the Immune Response - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:34:21Z","timestamp":1762598061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644823000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443184321"],"references-count":160,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2023.03.005","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}